Terms: = Prostate cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3
153 results:
1. Multifaceted impact of adipose conditioned media: Obesity-driven promotion of prostate cancer and cancer stem cell dynamics.
Erdogan S; Serttas R; Dibirdik I; Turkekul K
Cell Biochem Funct; 2024 Mar; 42(2):e3979. PubMed ID: 38481004
[TBL] [Abstract] [Full Text] [Related]
2. Resistance to 2-Hydroxy-Flutamide in prostate cancer Cells Is Associated with the Downregulation of Phosphatidylcholine Biosynthesis and Epigenetic Modifications.
Mora-Rodríguez JM; Sánchez BG; Sebastián-Martín A; Díaz-Yuste A; Sánchez-Chapado M; Palacín AM; Sánchez-Rodríguez C; Bort A; Díaz-Laviada I
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958610
[TBL] [Abstract] [Full Text] [Related]
3. prostate cancer Stem Cells: Biology and Treatment Implications.
Koukourakis IM; Platoni K; Kouloulias V; Arelaki S; Zygogianni A
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834336
[TBL] [Abstract] [Full Text] [Related]
4. Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in prostate cancer.
Grillo G; Keshavarzian T; Linder S; Arlidge C; Mout L; Nand A; Teng M; Qamra A; Zhou S; Kron KJ; Murison A; Hawley JR; Fraser M; van der Kwast TH; Raj GV; He HH; Zwart W; Lupien M
Cancer Discov; 2023 Nov; 13(11):2470-2487. PubMed ID: 37694973
[TBL] [Abstract] [Full Text] [Related]
5. Epigenetic regulation of pluripotency inducer genes NANOG and SOX2 in human prostate cancer.
Niharika ; Roy A; Mishra J; Chakraborty S; Singh SP; Patra SK
Prog Mol Biol Transl Sci; 2023; 197():241-260. PubMed ID: 37019595
[TBL] [Abstract] [Full Text] [Related]
6. cancer stem cell in prostate cancer progression, metastasis and therapy resistance.
Verma P; Shukla N; Kumari S; Ansari MS; Gautam NK; Patel GK
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188887. PubMed ID: 36997008
[TBL] [Abstract] [Full Text] [Related]
7. Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway.
Liao Y; Luo Z; Liu Y; Xue W; He S; Chen X; Ren H; Yang X; Zhu D; Su Z; Huang Q; Guo H
J Ethnopharmacol; 2023 Apr; 305():116133. PubMed ID: 36603788
[TBL] [Abstract] [Full Text] [Related]
8. DNA barcoding and gene expression recording reveal the presence of cancer cells with unique properties during tumor progression.
Umeki Y; Ogawa N; Uegaki Y; Saga K; Kaneda Y; Nimura K
Cell Mol Life Sci; 2022 Dec; 80(1):17. PubMed ID: 36564568
[TBL] [Abstract] [Full Text] [Related]
9. Counterintuitive production of tumor-suppressive secretomes from oct4- and c-Myc-overexpressing tumor cells and MSCs.
Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
[No Abstract] [Full Text] [Related]
10. Role of Resveratrol as Radiosensitizer by Targeting cancer Stem Cells in Radioresistant prostate cancer Cells (PC-3).
El-Benhawy SA; Morsi MI; Fahmy EI; Soula MA; Khalil FAZF; Arab AR
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3823-3837. PubMed ID: 34967561
[TBL] [Abstract] [Full Text] [Related]
11. The opposing action of stromal cell proenkephalin and stem cell transcription factors in prostate cancer differentiation.
Liu AY
BMC Cancer; 2021 Dec; 21(1):1335. PubMed ID: 34911496
[TBL] [Abstract] [Full Text] [Related]
12. HN1L promotes stem cell-like properties by regulating TGF-β signaling pathway through targeting FOXP2 in prostate cancer.
Nong S; Wang Z; Wei Z; Ma L; Guan Y; Ni J
Cell Biol Int; 2022 Jan; 46(1):83-95. PubMed ID: 34519127
[TBL] [Abstract] [Full Text] [Related]
13. Design and Characterization of a Cell-Penetrating Peptide Derived from the SOX2 Transcription Factor.
Gandhi NS; Wang E; Sorolla A; Kan YJ; Malik A; Batra J; Young KA; Tie WJ; Blancafort P; Mancera RL
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502261
[TBL] [Abstract] [Full Text] [Related]
14. Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non- Small-Cell Lung cancer Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway.
Yiyan S; Yang S; Li D; Li W
Curr Cancer Drug Targets; 2022; 22(1):86-95. PubMed ID: 34325639
[TBL] [Abstract] [Full Text] [Related]
15. Reduced DAPK1 Expression Promotes Stem Cell-Like Characteristics of prostate cancer Cells by Activating ZEB1 via Hippo/YAP Signaling Pathway.
Nong S; Wei Z; Wang Z; Ma L; Guan Y; Ni J
Stem Cells Dev; 2021 Sep; 30(18):934-945. PubMed ID: 34289746
[TBL] [Abstract] [Full Text] [Related]
16. Somatic-Type Yolk Sac Tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.
Collins K; Alkashash AM; Hwang M; Kaimakliotis HZ; Cheng L; Idrees MT
Int J Surg Pathol; 2022 Apr; 30(2):207-213. PubMed ID: 34255554
[TBL] [Abstract] [Full Text] [Related]
17. Subtype-specific collaborative transcription factor networks are promoted by oct4 in the progression of prostate cancer.
Takayama KI; Kosaka T; Suzuki T; Hongo H; Oya M; Fujimura T; Suzuki Y; Inoue S
Nat Commun; 2021 Jun; 12(1):3766. PubMed ID: 34145268
[TBL] [Abstract] [Full Text] [Related]
18. Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p.
Wang H; Di X; Bi Y; Sun S; Wang T
Bioengineered; 2021 Dec; 12(1):1791-1802. PubMed ID: 33975517
[TBL] [Abstract] [Full Text] [Related]
19. Acetylation of interferon regulatory factor-5 suppresses androgen receptor and downregulates expression of Sox2.
Acidereli H; Turut FA; Cevik O
Cell Biochem Funct; 2021 Jul; 39(5):667-678. PubMed ID: 33780016
[TBL] [Abstract] [Full Text] [Related]
20. Use of miR‑145 and testicular nuclear receptor 4 inhibition to reduce chemoresistance to docetaxel in prostate cancer.
Zhu J; Qin P; Cao C; Dai G; Xu L; Yang D
Oncol Rep; 2021 Mar; 45(3):963-974. PubMed ID: 33650661
[TBL] [Abstract] [Full Text] [Related]
[Next]
